# A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors

> **NCT05202561** · PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital of Bengbu Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** RNA tumor vaccine
- **BIOLOGICAL:** RNA tumor vaccine+Navuliumab

## Key facts

- **NCT ID:** NCT05202561
- **Lead sponsor:** The First Affiliated Hospital of Bengbu Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-10
- **Primary completion:** 2023-01-19
- **Final completion:** 2024-01-19
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05202561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05202561, "A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05202561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*